Form 4: Nuo Therapeutics Director Pittman Acquires 135,000 Shares at $0.75 Each

Scott M. Pittman, a director and 10% owner of Nuo Therapeutics, Inc., purchased 135,000 shares of common stock at $0.75 per share on May 20, 2024, increasing his total holdings to 5,178,345 shares.

Summary

• On May 20, 2024, Scott M. Pittman, a director and 10% owner of Nuo Therapeutics, Inc. (AURX), acquired 135,000 shares of common stock.
• The purchase price was $0.75 per share.
• Following the transaction, Pittman's total beneficial ownership in Nuo Therapeutics amounts to 5,178,345 shares.
• The transaction was approved by the Board of Directors of the Issuer and Non-Employee Directors.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares at $0.75 can be interpreted as a sign of confidence, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding 10% or more of a company's shares) buy or sell the company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The purchase could positively influence shareholder sentiment.

Key Dates